• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Harrow Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    6/20/25 6:01:59 AM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $HROW alert in real time by email
    false 0001360214 0001360214 2025-06-18 2025-06-18 0001360214 us-gaap:CommonStockMember 2025-06-18 2025-06-18 0001360214 HROW:SixTwoFiveSeniorNotesDue2026Member 2025-06-18 2025-06-18 0001360214 HROW:ElevenPointEightSevenFiveSeniorNotesDue2027Member 2025-06-18 2025-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): June 18, 2025

     

    HARROW, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-35814   45-0567010

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    1A Burton Hills Blvd., Suite 200    
    Nashville, Tennessee   37215
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (615) 733-4730

     

    Not Applicable

     

    (Former Name or Former Address, if Changed Since Last Report)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of exchange on which registered
    Common Stock, $0.001 par value per share   HROW   The Nasdaq Stock Market LLC
    8.625% Senior Notes due 2026   HROWL   The Nasdaq Stock Market LLC
    11.875% Senior Notes due 2027   HROWM   The Nasdaq Stock Market LLC

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Act of 1934: Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     
     

     

    Item 5.07 Submission of Matters to a Vote of Security Holders.

     

    On June 18, 2025, the Company held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). The number of shares of common stock entitled to vote at the Annual Meeting was 36,685,171. The number of shares of common stock present or represented by valid proxy at the Annual Meeting was 31,271,714. All matters submitted to a binding vote of stockholders at the Annual Meeting were approved. The number of votes cast for and against, and the number of abstentions and broker non-votes with respect to the matters voted upon at the Annual Meeting, are set forth below:

     

    Proposal 1: Election of Directors

     

    Stockholders voted to elect to the Board of Directors the four (4) director nominees named in the Company’s proxy statement to serve until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified. The results of the voting were:

     

    Directors  For  Withheld  Broker Non-Vote
    Mark L. Baum  23,643,847  272,563  7,355,304
    Adrienne L. Graves  23,200,214  716,196  7,355,304
    Lauren P. Silvernail  23,624,033  292,377  7,355,304
    Perry J. Sternberg  23,616,257  300,153  7,355,304

     

    Proposal 2: Approval of the Harrow, Inc. 2025 Incentive Stock and Awards Plan

     

    Stockholders voted to approve the Harrow, Inc. 2025 Incentive Stock and Awards Plan. The results of the voting were:

     

    For  Against  Abstain  Broker Non-Vote
    21,700,605  1,773,539  442,266  7,355,304

     

    Proposal 3: Ratification of Auditors

     

    Stockholders ratified the selection of Crowe LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. The results of the voting were:

     

    For  Against  Abstain  Broker Non-Vote
    31,229,548  23,282  18,884  -

     

    Proposal 4: To approve on a non-binding, advisory basis, the compensation of the Company’s named executive officers.

     

    Stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers. The results of the voting were:

     

    For  Against  Abstain  Broker Non-Vote
    22,496,427  971,206  448,777  7,355,304

     

    Proposal 5: To approve on a non-binding, advisory basis, the frequency of a stockholder advisory vote on the compensation of the Company’s named executive officers.

     

    Stockholders approved, on a non-binding, advisory basis, a frequency of one year for a stockholder advisory vote on the compensation of the Company’s named executive officers. The results of the voting were:

     

    One Year  Two Years  Three Years  Abstain  Broker Non-Vote
    20,415,407  7,346  2,868,210  625,447  7,355,304

     

     
     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      HARROW, INC.
         
    Dated: June 20, 2025 By: /s/ Andrew R. Boll
        Andrew R. Boll
        Chief Financial Officer

     

     

     

     

    Get the next $HROW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HROW

    DatePrice TargetRatingAnalyst
    6/12/2025$62.00Buy
    BTIG Research
    6/10/2025Outperform
    William Blair
    2/6/2025$57.00Buy
    H.C. Wainwright
    12/4/2024$73.00 → $69.00Buy
    B. Riley Securities
    4/11/2024$24.00Buy
    Craig Hallum
    9/8/2022$17.00Buy
    B. Riley Securities
    10/14/2021$16.00Buy
    B. Riley Securities
    9/24/2021$15.00Buy
    Aegis Capital
    More analyst ratings